Molecular Mechanisms of Pharmacological Action
Circulating Biomarker Results From a Phase 2 Study of Seralutinib in Pulmonary Arterial Hypertension
Osterhout R, Boucly A, Benza RL, Channick RN, Chin KM, Frantz RP, Hemnes AR, Howard LS, Mclaughlin VV, Sitbon O, Vachiéry JL, Zamanian RT, Aranda[...]